• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四唑衍生物作为潜在抗结核和抗疟药物的最新进展。

Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.

机构信息

WuXi AppTec, Wuhan, Hubei, PR China.

WuXi AppTec, Wuhan, Hubei, PR China.

出版信息

Eur J Med Chem. 2019 Feb 1;163:404-412. doi: 10.1016/j.ejmech.2018.12.001. Epub 2018 Dec 3.

DOI:10.1016/j.ejmech.2018.12.001
PMID:30530192
Abstract

Tetrazole, a bioisostere of the carboxylic acid group, can replace the carboxyl group in drugs to increase the lipophilicity, bioavailability and reduce side effects. Tetrazole derivatives possess a broad-spectrum of biological properties including anti-tubercular and anti-malarial activities, and some tetrazole-based compounds have already been used in clinics for the treatment of various diseases. Therefore, tetrazole is an important pharmacophore in the development of new drugs. This review covers the recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents, and the structure-activity relationship is also discussed for the further rational design of tetrazole derivatives.

摘要

四唑是羧酸基团的生物等排体,可以替代药物中的羧基,增加亲脂性、生物利用度并降低副作用。四唑衍生物具有广泛的生物学特性,包括抗结核和抗疟疾活性,一些基于四唑的化合物已在临床上用于治疗各种疾病。因此,四唑是开发新药的重要药效团。本综述涵盖了四唑衍生物作为潜在抗结核和抗疟药物的最新进展,并讨论了构效关系,以进一步合理设计四唑衍生物。

相似文献

1
Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.四唑衍生物作为潜在抗结核和抗疟药物的最新进展。
Eur J Med Chem. 2019 Feb 1;163:404-412. doi: 10.1016/j.ejmech.2018.12.001. Epub 2018 Dec 3.
2
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.苯并呋喃衍生物及其抗结核、抗菌活性。
Eur J Med Chem. 2019 Jan 15;162:266-276. doi: 10.1016/j.ejmech.2018.11.025. Epub 2018 Nov 10.
3
Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.水溶性3,5-二硝基苯基四唑和恶二唑抗结核药物的研发。
Bioorg Med Chem. 2017 Oct 15;25(20):5468-5476. doi: 10.1016/j.bmc.2017.08.010. Epub 2017 Aug 8.
4
New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.新型基于甲基四唑的(Z)-5-亚苄基-2-(哌嗪-1-基)噻唑-4(3H)-酮杂化物作为强效抗结核药物
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4166-70. doi: 10.1016/j.bmcl.2014.07.061. Epub 2014 Jul 29.
5
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.3,5-二硝基苯甲酰基四唑类抗结核药物的构效关系研究。
Eur J Med Chem. 2017 Apr 21;130:419-432. doi: 10.1016/j.ejmech.2017.02.058. Epub 2017 Feb 28.
6
Current scenario of tetrazole hybrids for antibacterial activity.当前用于抗菌活性的四唑杂合体的情况。
Eur J Med Chem. 2019 Dec 15;184:111744. doi: 10.1016/j.ejmech.2019.111744. Epub 2019 Sep 27.
7
Tetrazole hybrids with potential anticancer activity.具有潜在抗癌活性的四唑类杂合物。
Eur J Med Chem. 2019 Sep 15;178:341-351. doi: 10.1016/j.ejmech.2019.05.071. Epub 2019 May 28.
8
Recent advances of imidazole-containing derivatives as anti-tubercular agents.含咪唑衍生物作为抗结核药物的最新进展。
Eur J Med Chem. 2018 Apr 25;150:347-365. doi: 10.1016/j.ejmech.2018.03.016. Epub 2018 Mar 7.
9
Tetrazole Derivatives as Promising Anticancer Agents.四唑衍生物作为有前途的抗癌剂。
Anticancer Agents Med Chem. 2018 Feb 7;17(14):1856-1868. doi: 10.2174/1871520617666170327143148.
10
5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials.5-取代四唑作为羧酸的生物电子等排体。谷胱甘肽还原酶抑制剂作为抗疟药的生物电子等排体及作用机制研究。
J Med Chem. 2004 Nov 18;47(24):5972-83. doi: 10.1021/jm0497545.

引用本文的文献

1
Biological Activities of Etodolac-Based Hydrazone, Thiazolidinone and Triazole Derivatives on Breast Cancer Cell Lines MCF-7 and MDA-MB-231.依托度酸基腙、噻唑烷酮和三唑衍生物对乳腺癌细胞系MCF-7和MDA-MB-231的生物活性
J Biochem Mol Toxicol. 2025 Aug;39(8):e70428. doi: 10.1002/jbt.70428.
2
Recent advances in metal-free catalysts for the synthesis of N-heterocyclic frameworks focusing on 5- and 6-membered rings: a review.用于合成含氮杂环骨架的无金属催化剂的最新进展:聚焦于五元环和六元环的综述
RSC Adv. 2025 Mar 31;15(13):9676-9755. doi: 10.1039/d5ra00962f. eCollection 2025 Mar 28.
3
Applications of catalytic systems containing DNA nucleobases (adenine, cytosine, guanine, and thymine) in organic reactions.
含DNA核碱基(腺嘌呤、胞嘧啶、鸟嘌呤和胸腺嘧啶)的催化体系在有机反应中的应用。
RSC Adv. 2025 Jan 31;15(5):3192-3218. doi: 10.1039/d4ra07996e. eCollection 2025 Jan 29.
4
Stereoselective Asymmetric Syntheses of Molecules with a 4,5-Dihydro-1-[1,2,4]-Triazoline Core Possessing an Acetylated Carbohydrate Appendage: Crystal Structure, Spectroscopy, and Pharmacology.具有乙酰化碳水化合物侧链的 4,5-二氢-1-[1,2,4]-三唑啉核心分子的立体选择性不对称合成:晶体结构、光谱和药理学。
Molecules. 2024 Jun 14;29(12):2839. doi: 10.3390/molecules29122839.
5
Synthesis, Biological Properties, and Molecular Docking Study of Novel 1,2,3-Triazole-8-quinolinol Hybrids.新型1,2,3-三唑-8-喹啉醇杂化物的合成、生物学性质及分子对接研究
ACS Omega. 2024 May 31;9(23):25395-25409. doi: 10.1021/acsomega.4c03906. eCollection 2024 Jun 11.
6
New tetrazolopyrrolidine-1,2,3-triazole analogues as potent anticancer agents: design, synthesis and molecular docking studies.新型四氮唑并吡咯烷-1,2,3-三唑类似物作为强效抗癌剂:设计、合成及分子对接研究
Mol Divers. 2024 Oct;28(5):3313-3329. doi: 10.1007/s11030-023-10762-z. Epub 2023 Nov 8.
7
B7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy.B7通过调节半胱天冬酶-3的表达诱导结肠癌细胞凋亡并抑制自噬。
Onco Targets Ther. 2023 Oct 27;16:867-883. doi: 10.2147/OTT.S429128. eCollection 2023.
8
Contemporary Developments in Ferrocene Chemistry: Physical, Chemical, Biological and Industrial Aspects.二茂铁化学的当代发展:物理、化学、生物及工业方面
Molecules. 2023 Jul 30;28(15):5765. doi: 10.3390/molecules28155765.
9
Synthesis, Characterization, Antitubercular Activity, and Molecular Docking Studies of Pyrazolylpyrazoline-Clubbed Triazole and Tetrazole Hybrids.吡唑基吡唑啉结合的三唑和四唑杂化物的合成、表征、抗结核活性及分子对接研究
ACS Omega. 2023 Jun 2;8(23):20262-20271. doi: 10.1021/acsomega.2c07267. eCollection 2023 Jun 13.
10
Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2.基于结构的 RdRp 抑制剂对 SARS-CoV-2 的药物设计。
Top Curr Chem (Cham). 2023 Jun 15;381(5):22. doi: 10.1007/s41061-023-00432-x.